Does ANTIHEMOPHILIC FACTOR HUMAN Cause Product preparation issue? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Product preparation issue have been filed in association with ANTIHEMOPHILIC FACTOR HUMAN. This represents 4.2% of all adverse event reports for ANTIHEMOPHILIC FACTOR HUMAN.
34
Reports of Product preparation issue with ANTIHEMOPHILIC FACTOR HUMAN
4.2%
of all ANTIHEMOPHILIC FACTOR HUMAN reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product preparation issue From ANTIHEMOPHILIC FACTOR HUMAN?
Of the 34 reports, 1 (2.9%) resulted in death, 1 (2.9%) required hospitalization.
Is Product preparation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANTIHEMOPHILIC FACTOR HUMAN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does ANTIHEMOPHILIC FACTOR HUMAN Cause?
Haemarthrosis (118)
Haemorrhage (112)
Drug ineffective (69)
No adverse event (64)
Epistaxis (43)
Acquired haemophilia (41)
Arthralgia (40)
Fall (37)
Device issue (36)
Pre-existing disease (36)
What Other Drugs Cause Product preparation issue?
ONABOTULINUMTOXINA (677)
COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (252)
HUMAN C1-ESTERASE INHIBITOR (238)
SOMATROPIN (200)
INCOBOTULINUMTOXINA (174)
STIRIPENTOL (129)
TESAMORELIN (119)
ABATACEPT (115)
INFLIXIMAB (101)
ABOBOTULINUMTOXINA (91)
Which ANTIHEMOPHILIC FACTOR HUMAN Alternatives Have Lower Product preparation issue Risk?
ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED
ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT
ANTIHEMOPHILIC FACTOR HUMAN vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT
ANTIHEMOPHILIC FACTOR HUMAN vs APALUTAMIDE